O

OrbiMed Portfolio holdings

AUM $4.89B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+87.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.36B
AUM Growth
-$2.91B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
161
New
Increased
Reduced
Closed

Top Buys

1
+$78.1M
2
+$77.1M
3
+$59.3M
4
CELG
Celgene Corp
CELG
+$58.5M
5
GH icon
Guardant Health
GH
+$56.5M

Top Sells

1
+$149M
2
+$98.5M
3
+$81.7M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$81M
5
EW icon
Edwards Lifesciences
EW
+$79.7M

Sector Composition

1 Healthcare 96%
2 Financials 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$14.8M 0.28%
9,207,012
77
$14.2M 0.27%
135,333
78
$13.6M 0.25%
1,440,000
79
$12.8M 0.24%
3,409,865
80
$12.1M 0.23%
3,298,516
81
$12.1M 0.23%
1,250,396
82
$12.1M 0.23%
147,973
83
$9.65M 0.18%
+562,785
84
$9.55M 0.18%
684,086
85
$9.45M 0.18%
75,900
86
$9.15M 0.17%
175,000
-25,000
87
$9.12M 0.17%
824,549
-450,000
88
$8.83M 0.16%
346,263
89
$7.77M 0.15%
1,350,655
+684,062
90
$7.42M 0.14%
1,031,596
91
$6.78M 0.13%
18,578
92
$6.51M 0.12%
76,500
93
$5.72M 0.11%
350,000
94
$5.46M 0.1%
21,500
95
$5.15M 0.1%
377,600
-367,000
96
$4.82M 0.09%
+47,800
97
$4.53M 0.08%
469,953
+216,770
98
$4.34M 0.08%
10,383
99
$4.31M 0.08%
+327,000
100
$4.2M 0.08%
52,635
-3,792
2 3
4
5 6